Anthem Biosciences share price
Anthem Biosciences Ltd. · NSE: ANTHEM · Healthcare
Price, one year
Price range
- Open
- ₹795.00
- High
- ₹817.80
- Low
- ₹783.35
- Previous close
- ₹800.75
- Volume
- 5.4 L
- Market cap
- ₹45,804 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 79.3
- Price to book
- 15.1
- Return on equity
- 18.9%
- EPS (TTM)
- ₹10.25
- Book value / share
- ₹53.99
- Debt to equity
- 0.02
- Revenue (TTM)
- ₹2,002 Cr
- Net profit (TTM)
- ₹576 Cr
- Sales growth, YoY
- −22.6%
- Profit growth, YoY
- −11.7%
- Operating margin
- 39.6%
- Net margin
- 28.8%
- Sales CAGR, 3 years
- —
- Profit CAGR, 3 years
- —
- Promoter holding
- 71.40%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 74.68 | 71.42 | 71.40 |
| Foreign institutions | 1.28 | 2.58 | 3.79 |
| Domestic institutions | 11.55 | 13.48 | 12.10 |
| Mutual funds | 10.12 | 11.15 | 9.25 |
| Retail and others | 9.37 | 9.42 | 9.47 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 21 Jul 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Anthem Biosciences today?
Anthem Biosciences (NSE: ANTHEM) was at ₹812.80 on 23 Oct 2026, a change of +1.50% from the previous close.
What are the 52-week high and low of Anthem Biosciences?
Over the last 52 weeks Anthem Biosciences traded between ₹579.15 and ₹977.55 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Anthem Biosciences?
About ₹45,804 Cr at the latest price, with a P/E of 79.3, a price-to-book of 15.1, a return on equity of 18.9%. Ratios use the company's latest reported results.
Who owns Anthem Biosciences shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 71.40%, foreign institutions 3.79%, domestic institutions 12.10%.
Which sector and indices does Anthem Biosciences belong to?
NSE classifies Anthem Biosciences under Healthcare; it is a member of Nifty 500.
Follow Anthem Biosciences with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial